2章 FN に対 治療 - JCQHC

第Ⅷ章 急性腹症の検査 - minds4.jcqhc.or.jp

Ⅷ急性腹症の検査 81 引用文献 1） 前田重信．時間外外来における検査．救急医学 2010 ; 34 : 982─4. ic 2010291864（レベル5）

1章 FN の概要と初期評価 - minds4.jcqhc.or.jp

4 ステートメント（推奨グレード） mascc スコアを用いた高リスクと低リスクの分類が有用である． 背景・目的

う蝕治療 ガイドライン - minds4.jcqhc.or.jp

ii 『う蝕治療ガイドライン』 iii 序 診療ガイドラインとは、「医療者と患者が特定の臨床状況で適切な決断を下せるよう支援 ...

  Minds4, Jcqhc

発熱性好中球減少症 FN 診療ガイドライン

v 発熱性好中球減少症は，血液疾患や固形がんの治療経過中に好中球減少をきたして発熱を伴 い，時として重篤な感染症に発展し死に至ることもある，緊急事態として対応することが要求

システマティックレビューの概要

32 第4章 システマティックレビュー ものである。スコープに記載されたシステマティックレビュー方法論を確認・検討

治 療 - Mindsガイドラインライブラリ

4.1．手術適応・保存的治療 43 文 献 1 ） KF00817 Mizuta H, Kubota K, Shiraishi M et al：The conservative treatment of complete tears of the anterior cruciate ligament in skeletally immature

  Anterior, Anterior cruciate ligament, Cruciate, Ligament

¶ s ú O ¨Åå ï - Mindsガイドラインライブラリ

¨ Åå ï~ tKhlo è $q&¢ ¨ Åå ïxzô ¸ p ú Ä Åw à SUôXz`T O ± «U M\q q`ozô ¸ ú Ow ¶ Q ô è $p åt s o^

Japanese Orthopaedic Association ... - …

v 日本整形外科学会診療ガイドライン改訂にあたって 高齢社会を迎えたわが国では，2010年時点の平均寿命が男性79.6歳，女性が

予 防 - Mindsガイドラインライブラリ

70 第5章 予 防 back pain questionnaire（☞用語解説72頁）（疼痛と機能障害を評価する16設問 の自記式評価法）とミネソタ多面人格目録（☞用語解説73頁）（Minnesota multi­

  Questionnaire, Back, Pain, Back pain questionnaire

用語解説 - Mindsガイドラインライブラリ

用語解説 用語解説 73 など，16項目の質問に対し0〜6の7段階で自己評価を行い，これを合計して点数 化する． fear-avoidance beliefs（恐怖回避信念）

EMPIRIC TREATMENT OF FEBRILE NEUTROPENIA

1. Freifeld AG, Bow EJ, Sepkowitz KA, et al. Clinical practice guideline for the use of antimicrobial agents in neutropenic patients with cancer: 2010 update by the Infectious Diseases Society of America. Clin Infect Dis 2011;52(4):e56-e93. 2.

  Patients, Antimicrobial, Agent, Neutropenic, Antimicrobial agents in neutropenic patients

Medication Administration: Extended-Infusion Piperacillin ...

abstracts of the 42nd interscience conference on antimicrobial agents and chemotherapy. 2002. 9. Ariano RE, Nyhlen A, Donnelly JP, Sitar DS, Harding GK, Zelenitsky SA. Pharmacokinetics and pharmacodynamics of meropenem in febrile neutropenic patients with bacteremia. The Annals of pharmacotherapy. Jan 2005;39(1):32-38. 10.

  Patients, Antimicrobial, Agent, Neutropenic, Antimicrobial agents, Neutropenic patients

Staphylococcus aureus Bloodstream Infection Treatment ...

6. Not immunosuppressed or neutropenic 7. Removal of any indwelling catheter ii. It is unknown if transition to oral therapy is safe but in patients with low risk conditions (UTI or skin/soft tissue infection without residual abscess) who meet criteria for uncomplicated BSI transition to active oral agents with good oral

  Patients, Agent, Neutropenic

NCCN Clinical Practice Guidelines in Oncology (NCCN ...

For MDS (neutropenic), AML (neutropenic), and Significant GVHD, "Micafungin (category 2B)" was added. For Allogeneic HCT (neutropenic), Itraconazole (category 2B) was removed. Footnote "k" revised: "Consider antifungal prophylaxis in all patients with GVHD receiving immunosuppressive therapy (IST)"

  Guidelines, Patients, Neutropenic

Clinical Practice Guidelines for the Diagnosis and ...

neutropenic patients, severely ill patients with sepsis, or patients known to be colonized with such pathogens, until the culture and susceptibility data are available and de-escalation of the antibiotic regimen can be done (A-II). 27. In addition to coverage for gram-positivepathogens,em-pirical therapy for suspected CRBSI involving femoral ...

  Patients, Neutropenic, Neutropenic patients

Clinical Practice Guideline for Sepsis Treatment ...

broaden antimicrobial activity.) Combination therapy for the routine treatment of Neutropenic Sepsis/Bacteremia. (This does not preclude the use of multidrug therapy to broaden antimicrobial activity.) 4) Administer bolus: 30 ml/kg Crystalloid for hypotension or a …

  Antimicrobial, Neutropenic

Methicillin-Resistant Staphylococcus Aureus (MRSA)

2. Empiric treatment for febrile neutropenic patients unless a gram-positive infection is suspected and the institution has a high rate of MRSA. 3. Treatment of one positive blood culture for coagulase-negative staphylococcus if other blood cultures drawn at the same time are negative (i.e., likely contamination). 4.

  Patients, Neutropenic, Neutropenic patients

n GUIDELINES FOR TREATMENT OF CLOSTRIDIUM …

In patients who do not have the entire colon in place (i.e., a colorectal stump due to Hartman [s procedure), a smaller volume of enema (100 mL) is acceptable. 6. Avoid multiple or prolonged courses of metronidazole in recurrent disease due to the risk for cumulative neurotoxicity. 7. Alternative and/or adjunctive agents: a.

  Guidelines, Patients, Treatment, Clostridium, Agent, Guidelines for treatment of clostridium

Methicillin-Resistant Staphylococcus Aureus (MRSA)

2. Empiric treatment for febrile neutropenic patients unless a gram-positive infection is suspected and the institution has a high rate of MRSA. 3. Treatment of one positive blood culture for coagulase-negative staphylococcus if other blood cultures drawn at the same time are negative (i.e., likely contamination). 4.

  Patients, Neutropenic, Neutropenic patients

Symptom Management Guidelines: FEVER and NEUTROPENIA

Antibiotic prophylaxis may be considered in patients with expected duration of neutropenia (ANC <1.0 X 109/L )) for > 7 days or for patients receiving immunosuppressive regimens (e.g. systemic corticosteroids). Antifungal prophylaxis may be recommended for high risk patients (e.g. those with acute leukemia and stem cell transplantation).

  Patients